Prudential Financial’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-10,655
Closed -$13.5K 2527
2026
Q1
$13.5K Buy
+10,655
New +$20K ﹤0.01% 2389
2025
Q2
Sell
-31,931
Closed -$145K 2460
2025
Q1
$145K Buy
+31,931
New +$169K ﹤0.01% 2102
2022
Q1
Sell
-4,209
Closed -$223K 2640
2021
Q4
$223K Sell
4,209
-204
-5% -$9.3K ﹤0.01% 2508
2021
Q3
$244K Buy
4,413
+640
+17% +$34.9K ﹤0.01% 2408
2021
Q2
$210K Buy
+3,773
New +$201K ﹤0.01% 2440

Other funds holding HCAT

Prudential Financial's HCAT Position: Q2 2026 in Review

Prudential Financial sold out of Health Catalyst (HCAT) in Q2 2026, closing a stake of 10,655 shares — an estimated $13.5K sold.

Prudential Financial first reported a position in HCAT in Q2 2021 and held it in 5 quarters. The position peaked at $244K in Q3 2021. 127 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • Prudential Financial reported no remaining Health Catalyst position as of Q2 2026 after selling out during the quarter.
  • Prudential Financial sold 10,655 Health Catalyst shares in Q2 2026, an estimated $13.5K.
  • Prudential Financial first reported a position in Health Catalyst in Q2 2021 and held it in 5 quarters.
  • Prudential Financial's Health Catalyst position peaked at $244K in Q3 2021.
  • 127 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.